A Glimpse of the SILEX Uranium Enrichment Process
A relatively new technology for enriching uranium known as “Separation of Isotopes by Laser Excitation” or SILEX is described in some fresh detail in a recent Los Alamos paper (pdf).
SILEX, developed in 1992 by Australian scientists, is the rarest of birds in U.S. classification policy: It is privately generated information that is nevertheless classified by the U.S. government.
Ordinarily, information must be owned or controlled by the government in order to be eligible for classification in the first place. But under the peculiar terms of the Atomic Energy Act, the government may impose classification on “all” information concerning nuclear weapons and related matters that has not been previously declassified.
Since the new SILEX technology has never been declassified, it is ipso facto classified, despite the fact that it was generated by private (and foreign) researchers. It is the only known case in which the Atomic Energy Act has been used in this constitutionally questionable manner. (See Secrecy News, 06/26/01).
Unclassified details of the SILEX process, which uses pulsed lasers to selectively excite uranium hexafluoride molecules containing uranium-235, are presented in “Enrichment Separative Capacity for SILEX” by John L. Lyman, Los Alamos National Laboratory, LA-UR-05-3786 (thanks to WT).
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.